The new Drug Price Control Order (DPCO) which is enforced from May 15 is seen as a double edged sword. While it may reduce the prices of many of... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75430&sid=1(Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia... ...
http://feeds.reuters.com/~r/reuters/INhealth/~3/1MrybbhJN-E/us-novonordisk-haemophilia-idINBRE94G0E320130517Novo Nordisk today announced thecompletion of paradigm™ 2, the first phase 3 trial with a long-actingFIX derivative, N9-GP (glycopegylated... ...
http://feedproxy.google.com/~r/Andhranewsnet-NewsFeatureUpdates/~3/8EDuwt2peJU/Novo-Nordisk-reports-positive-results-first-21817.htmLONDON, May 17 (Reuters) - European stocks were expected to edge lower on Friday, mirroring losses on Wall Street, following comments from some... ...
http://in.reuters.com/article/2013/05/17/markets-europe-factors-idINL6N0DY05620130517Contest raised over $53,000 for organizations committed to diabetes awareness, education and support PR Newswire PRINCETON, N.J., May 16, 2013... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45435